Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471308) titled 'P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation' on March 10.

Study Type: Observational

Primary Sponsor: CathVision ApS

Condition: Atrial Fibrillation (AF) Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System Atrial Fibrillation (Paroxysmal) Pulmonary Vein Isolation

Recruitment Status: Not recruiting

Date of First Enrollment: February 2026

Target Sample Size: 300

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07471308

Disclaimer: Curated by HT Syndication....